NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
23.83
+0.34 (1.45%)
At close: Oct 30, 2026, 4:00 PM EDT
23.84
+0.01 (0.02%)
After-hours: Oct 30, 2026, 7:30 PM EDT
NRC Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 143.79 | 137.39 | 143.06 | 148.58 | 151.57 | 147.95 | |
Revenue Growth | 3.37% | -3.96% | -3.72% | -1.97% | 2.44% | 11.01% |
Cost of Revenue | 56.52 | 52.37 | 56.93 | 56.02 | 57.05 | 52.35 |
Gross Profit | 87.27 | 85.02 | 86.13 | 92.57 | 94.52 | 95.6 |
Selling, General & Admin | 56.07 | 48.02 | 44.65 | 46.58 | 42.69 | 38.81 |
Operating Expenses | 64.57 | 55.64 | 50.67 | 52.48 | 47.96 | 44.86 |
Operating Income | 22.7 | 29.38 | 35.45 | 40.09 | 46.56 | 50.74 |
Interest Expense | -5.48 | -4.76 | -2.6 | -0.86 | -1.21 | -1.67 |
Interest & Investment Income | 0.11 | 0.11 | 0.13 | 0.82 | 0.17 | 0.01 |
Other Non Operating Income (Expenses) | -0.03 | -0.1 | -0.03 | -0.04 | -2.69 | 0 |
EBT Excluding Unusual Items | 17.3 | 24.63 | 32.95 | 40 | 42.83 | 49.1 |
Merger & Restructuring Charges | - | - | -0.12 | - | - | -0.12 |
Asset Writedown | -0.01 | -0.01 | -0.06 | -0.04 | -0.01 | -0.36 |
Other Unusual Items | -6.78 | -6.78 | -0.08 | - | - | - |
Pretax Income | 10.51 | 17.85 | 32.69 | 39.96 | 42.82 | 48.62 |
Income Tax Expense | 4.07 | 6.25 | 7.91 | 8.99 | 11.02 | 11.16 |
Net Income | 6.44 | 11.6 | 24.78 | 30.97 | 31.8 | 37.47 |
Preferred Dividends & Other Adjustments | 0.31 | 0.31 | 0 | 0.01 | 0.02 | 0.02 |
Net Income to Common | 6.13 | 11.29 | 24.78 | 30.96 | 31.78 | 37.45 |
Net Income Growth | -62.02% | -54.43% | -19.97% | -2.58% | -15.13% | 0.66% |
Shares Outstanding (Basic) | 22 | 22 | 24 | 25 | 25 | 25 |
Shares Outstanding (Diluted) | 22 | 22 | 24 | 25 | 25 | 26 |
Shares Change | -3.57% | -5.67% | -3.77% | -1.51% | -2.29% | -0.22% |
EPS (Basic) | 0.28 | 0.50 | 1.05 | 1.26 | 1.28 | 1.47 |
EPS (Diluted) | 0.27 | 0.50 | 1.04 | 1.25 | 1.27 | 1.46 |
EPS Growth | -62.20% | -51.92% | -16.80% | -1.57% | -13.01% | 0.69% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 18.45 | 15.74 | 19.18 | 22.33 | 26.43 | 40.83 |
Free Cash Flow Per Share | 0.84 | 0.70 | 0.81 | 0.91 | 1.05 | 1.59 |
Dividend Per Share | 0.640 | 0.520 | 0.480 | 0.480 | 0.840 | 0.480 |
Dividend Growth | 33.33% | 8.33% | 0% | -42.86% | 75.00% | 128.57% |
Gross Margin | 60.69% | 61.88% | 60.20% | 62.30% | 62.36% | 64.62% |
Operating Margin | 15.78% | 21.38% | 24.78% | 26.98% | 30.72% | 34.30% |
Profit Margin | 4.26% | 8.22% | 17.32% | 20.84% | 20.97% | 25.31% |
Free Cash Flow Margin | 12.83% | 11.46% | 13.41% | 15.03% | 17.44% | 27.60% |
EBITDA | 31.2 | 37 | 41.48 | 45.99 | 51.83 | 56.79 |
EBITDA Margin | 21.70% | 26.93% | 28.99% | 30.95% | 34.20% | 38.39% |
D&A For EBITDA | 8.5 | 7.62 | 6.02 | 5.9 | 5.28 | 6.05 |
EBIT | 22.7 | 29.38 | 35.45 | 40.09 | 46.56 | 50.74 |
EBIT Margin | 15.78% | 21.38% | 24.78% | 26.98% | 30.72% | 34.30% |
Effective Tax Rate | 38.73% | 35.00% | 24.19% | 22.50% | 25.73% | 22.94% |